Marcos Quintela
Singleton Park
Swansea, WLS, United Kingdom
Swansea, WLS, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Distinct H3K27 Methylation States Drive Cellular Responses to the Histone Demethylase Inhibitor GSK-J4 in Ovarian Cancer Cells.
Journal: Molecular cancer therapeutics
Published: March 12, 2025
Distinct H3K27 methylation states drive cellular responses to the histone demethylase inhibitor GSK-J4 in ovarian cancer cells.
Journal: Molecular cancer therapeutics
Published: March 12, 2025
Ferroptosis: An emerging strategy for managing epithelial ovarian cancer.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: January 09, 2025
Cisplatin resistance alters ovarian cancer spheroid formation and impacts peritoneal invasion.
Journal: Frontiers in cell and developmental biology
Published: June 17, 2024
Corrigendum: Homeobox regulator Wilms Tumour 1 is displaced by androgen receptor at cis-regulatory elements in the endometrium of PCOS patients.
Journal: Frontiers in endocrinology
Published: June 17, 2024
Homeobox regulator Wilms Tumour 1 is displaced by androgen receptor at cis-regulatory elements in the endometrium of PCOS patients.
Journal: Frontiers in endocrinology
Published: January 10, 2024
Development and Characterisation of a New Patient-Derived Xenograft Model of AR-Negative Metastatic Castration-Resistant Prostate Cancer.
Journal: Cells
Published: December 22, 2023
Transcriptomic analysis reveals the anti-cancer effect of gestational mesenchymal stem cell secretome.
Journal: Stem cells translational medicine
Published: September 12, 2023
Transcriptomic analysis of stem cells from chorionic villi uncovers the impact of chromosomes 2, 6 and 22 in the clinical manifestations of Down syndrome.
Journal: Stem cell research & therapy
Published: April 10, 2023
Selenium nanoparticles modulate histone methylation via lysine methyltransferase activity and S-adenosylhomocysteine depletion.
Journal: Redox biology
Published: February 02, 2023
In silico enhancer mining reveals SNS-032 and EHMT2 inhibitors as therapeutic candidates in high-grade serous ovarian cancer.
Journal: British journal of cancer
Published: October 17, 2022
Bromodomain inhibitor i-BET858 triggers a unique transcriptional response coupled to enhanced DNA damage, cell cycle arrest and apoptosis in high-grade ovarian carcinoma cells.
Journal: Clinical epigenetics
Published: June 08, 2022
Last Updated: 09/26/2026